Skip to content

Text Size: AAA

Investors

Printer Friendly Version Print  |  E-mail this page Email  |  E-mail Alerts Alerts  |  RSS RSS  |  View contacts Contacts  |  Download Financial Tear Sheet Tear Sheet

Webcast ImageWebcast
Amylin Pharmaceuticals, Inc. Annual Shareholder Meeting (Replay)
05/15/12 at 9:00 a.m. PT
Our Investor Relations Center is provided to give you convenient access to company information, including financial reports, press releases and corporate events. You can also sign up to be reminded via email of any upcoming company presentations, or to be notified of news releases and other announcements.

If you cannot find the information you're looking for on our website please let us know, and we will do our best to accommodate your request.
Featured Report
Download Documentation 2011 Annual Report
RECEIVE E-MAIL ALERTS
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!
Stock Quote
AMLN (Common)
ExchangeNASDAQ (US Dollar)
Price$27.54
Change (%) Stock is Up 0.24 (0.88%)
Volume4,915,492
Data as of 05/16/12 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore
DateTitle 
05/08/12Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
SAN DIEGO--(BUSINESS WIRE)--May. 8, 2012-- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast its Annual Meeting of Stockholders on Tuesday, May 15, 2012 at 9:00 a.m. PT/ 12:00 p.m. ET from the Company's corporate headquarters in San Diego. Following the Annual Meeting, Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will provide a corporate overview. The call will be webcast live through the ... 
Printer Friendly Version
04/30/12Amylin Pharmaceuticals to Present at Deutsche Bank 37th Annual Health Care Conference
SAN DIEGO--(BUSINESS WIRE)--Apr. 30, 2012-- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Deutsche Bank 37th Annual Health Care Conference on Monday, May 7, 2012 at 2:10 p.m. ET / 11:10 a.m. PT in Boston. Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will provide a corporate overview. The presentation will be webcast through the “Investors” section of Amylin’s corporate web... 
Printer Friendly Version
04/26/12Amylin Pharmaceuticals Reports First Quarter 2012 Financial Results
BYDUREON, First and Only Weekly Treatment for Type 2 Diabetes, Launched in the U.S. SAN DIEGO, Apr 26, 2012 (BUSINESS WIRE) --Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today reported financial results for the quarter ended March 31, 2012. Total revenue for the quarter ended March 31, 2012 was $153.7 million, which included net product sales of $150.6 million. Non-GAAP operating loss for the quarter ended Mar... 
Printer Friendly Version
04/19/12Amylin Pharmaceuticals to Webcast First Quarter Results
SAN DIEGO, Apr 19, 2012 (BUSINESS WIRE) --Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast its Quarterly Update Conference Call for the first quarter of 2012 on Thursday, April 26, 2012 at 8:30 a.m. ET/5:30 a.m. PT. Daniel M. Bradbury, Amylin's president and chief executive officer, will lead the call. On the same date pre-market, Amylin will release financial results for the first quarter of 2012. The call will be webcast live through t... 
Printer Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.